FFO
EGRX

Fortitude Family Office’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Fortitude Family Office’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-117
Closed -$613 – 1075
2024
Q1 		$613 Buy
+117
New +$613 ﹤0.01% 925